• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为强效α-葡萄糖苷酶抑制剂的苯氧基乙基异吲哚酮腙的合成、结构见解及生物评价

Synthesis, structural insights and bio-evaluation of -phenoxyethylisatin hydrazones as potent α-glucosidase inhibitors.

作者信息

Mehreen Saba, Ali Muhammad Imran, Muntha Sidra Tul, Zia Mehwash, Ullah Aman, Ullah Saeed, Khan Ajmal, Hussain Javid, Anwar Muhammad U, Al-Harrasi Ahmed, Naseer Muhammad Moazzam

机构信息

Department of Chemistry, Quaid-i-Azam University Islamabad 45320 Pakistan

Department of Chemistry, Faculty of Sciences, The University of Haripur KP 22620 Pakistan.

出版信息

RSC Adv. 2025 May 7;15(19):14717-14729. doi: 10.1039/d5ra00770d. eCollection 2025 May 6.

DOI:10.1039/d5ra00770d
PMID:40337235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12056728/
Abstract

Effective α-glucosidase inhibitors are vital for managing type 2 diabetes, emphasizing the need for novel and potent compounds. A series of novel -phenoxyethylisatin hydrazones 1(a-l) have been synthesized and characterized by their spectral data, and in the case of 1l by its single crystal X-ray analysis. All the synthesized compounds were evaluated for their inhibition potential against the α-glucosidase enzyme. Interestingly, most of these compounds exhibited significant inhibitory activity against the α-glucosidase enzyme, with IC values ranging from 3.64 ± 0.13 to 94.89 ± 0.64 μM compared to the standard drug, acarbose (IC = 873.34 ± 1.67 μM). The compound 1e was found to be the most active compound of the series having an IC value of 3.64 ± 0.13 μM. Molecular docking studies revealed a binding score of -9.7 kcal mol for 1e, slightly surpassing that of acarbose (-9.4 kcal mol). Unlike acarbose, which primarily relies on hydrogen bonding, the binding interactions of 1e are dominated by π-interactions. ADMET profiling confirmed favourable pharmacokinetics for these compounds, including good oral bioavailability, balanced hydrophilicity, and minimal predicted toxicity. These findings highlight the potential of these compounds as promising candidates for the development of more effective treatments for hyperglycemia.

摘要

有效的α-葡萄糖苷酶抑制剂对2型糖尿病的管理至关重要,这凸显了对新型高效化合物的需求。一系列新型的苯氧乙基异吲哚酮腙1(a - l)已被合成,并通过光谱数据进行了表征,其中1l还通过单晶X射线分析进行了表征。所有合成的化合物都针对其对α-葡萄糖苷酶的抑制潜力进行了评估。有趣的是,这些化合物中的大多数对α-葡萄糖苷酶表现出显著的抑制活性,与标准药物阿卡波糖(IC = 873.34 ± 1.67 μM)相比,其IC值范围为3.64 ± 0.13至94.89 ± 0.64 μM。化合物1e被发现是该系列中活性最高的化合物,IC值为3.64 ± 0.13 μM。分子对接研究表明1e的结合分数为-9.7 kcal/mol,略高于阿卡波糖(-9.4 kcal/mol)。与主要依赖氢键的阿卡波糖不同,1e的结合相互作用以π-相互作用为主。ADMET分析证实这些化合物具有良好的药代动力学性质,包括良好的口服生物利用度、平衡的亲水性和最小的预测毒性。这些发现突出了这些化合物作为开发更有效高血糖治疗方法的有前景候选物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/3a3c3063bbb3/d5ra00770d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/1c046e2bf0d4/d5ra00770d-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/2244b0e724d4/d5ra00770d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/17c3fc9b21ac/d5ra00770d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/57c9d27e2774/d5ra00770d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/69a7db8ecf93/d5ra00770d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/052ec52e94e8/d5ra00770d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/3a3c3063bbb3/d5ra00770d-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/1c046e2bf0d4/d5ra00770d-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/2244b0e724d4/d5ra00770d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/17c3fc9b21ac/d5ra00770d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/57c9d27e2774/d5ra00770d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/69a7db8ecf93/d5ra00770d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/052ec52e94e8/d5ra00770d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2b3/12056728/3a3c3063bbb3/d5ra00770d-f6.jpg

相似文献

1
Synthesis, structural insights and bio-evaluation of -phenoxyethylisatin hydrazones as potent α-glucosidase inhibitors.作为强效α-葡萄糖苷酶抑制剂的苯氧基乙基异吲哚酮腙的合成、结构见解及生物评价
RSC Adv. 2025 May 7;15(19):14717-14729. doi: 10.1039/d5ra00770d. eCollection 2025 May 6.
2
Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.揭示新型噻唑-磺酰胺衍生物的抗糖尿病潜力:设计、合成、针对 DPP-4、α-葡萄糖苷酶和α-淀粉酶的体外生物评价以及基于计算机的 ADMET 和对接模拟。
Bioorg Chem. 2024 Oct;151:107671. doi: 10.1016/j.bioorg.2024.107671. Epub 2024 Jul 23.
3
Design, synthesis, and inhibition of α-glucosidase by novel l-phenylalanine-derived hydrazones: Kinetic, molecular docking, and dynamics studies.新型L-苯丙氨酸衍生腙的设计、合成及其对α-葡萄糖苷酶的抑制作用:动力学、分子对接及动力学研究
Arch Biochem Biophys. 2025 Jun;768:110368. doi: 10.1016/j.abb.2025.110368. Epub 2025 Mar 4.
4
Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.三唑稠合吲哚衍生物的设计、合成及α-葡萄糖苷酶抑制活性研究。
Bioorg Chem. 2023 Oct;139:106750. doi: 10.1016/j.bioorg.2023.106750. Epub 2023 Jul 23.
5
Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase.噻吩并[2,3 - b]喹啉腙作为新型α - 葡萄糖苷酶抑制剂的设计、合成、体外及计算机酶学评价
Bioorg Chem. 2022 Oct;127:105996. doi: 10.1016/j.bioorg.2022.105996. Epub 2022 Jul 19.
6
Design, synthesis, in-vitro and in-silico studies of novel N-heterocycle based hydrazones as α-glucosidase inhibitors.新型基于N-杂环的腙类α-葡萄糖苷酶抑制剂的设计、合成、体外及计算机模拟研究
Bioorg Chem. 2025 Mar;156:108155. doi: 10.1016/j.bioorg.2025.108155. Epub 2025 Jan 10.
7
Study on the Interaction of 1,5-diaryl Pyrrole Derivatives with α- glucosidase; Synthesis, Molecular Docking, and Kinetic Study.1,5-二芳基吡咯衍生物与α-葡萄糖苷酶相互作用的研究;合成、分子对接和动力学研究。
Med Chem. 2021;17(5):545-553. doi: 10.2174/1573406415666191206100336.
8
In-vitro high-throughput library screening-Kinetics and molecular docking studies of potent inhibitors of α-glucosidase.体外高通量文库筛选 - α-葡萄糖苷酶强效抑制剂的动力学和分子对接研究。
PLoS One. 2023 Jun 30;18(6):e0286159. doi: 10.1371/journal.pone.0286159. eCollection 2023.
9
Carbonylbis(hydrazine-1-carbothioamide) derivatives as a new class of α-glucosidase inhibitors and their mechanistic insights via molecular docking and dynamic simulations.羰基双(肼-1-碳硫酰胺)衍生物作为一类新型的α-葡萄糖苷酶抑制剂及其通过分子对接和动态模拟的作用机制研究。
Arch Pharm (Weinheim). 2024 Mar;357(3):e2300604. doi: 10.1002/ardp.202300604. Epub 2023 Dec 26.
10
Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.基于对乙酰氨基酚与磺胺类药物结合的新型抗糖尿病潜在药物的发现:设计、合成、α-淀粉酶和α-葡萄糖苷酶抑制剂及分子对接模拟。
Eur J Med Chem. 2024 Sep 5;275:116589. doi: 10.1016/j.ejmech.2024.116589. Epub 2024 Jun 8.

本文引用的文献

1
Synthesis, Characterization, Bioevaluation, and Docking Studies of Spiroisatin-Based Hydrazide Conjugates.基于螺吲哚满二酮的酰肼共轭物的合成、表征、生物评价及对接研究
Chem Biodivers. 2025 Mar 23:e202403440. doi: 10.1002/cbdv.202403440.
2
Intramolecular noncovalent C-bonding driven conformational preference in spiroisatin-based -acyl hydrazones.基于螺吲哚满二酮的α-酰腙中分子内非共价C键驱动的构象偏好
RSC Adv. 2025 Jan 13;15(2):1152-1162. doi: 10.1039/d4ra08086f. eCollection 2025 Jan 9.
3
Investigation of Newly Synthesized Fluorinated Isatin-Hydrazones by Antiproliferative Activity, Molecular Docking, ADME Analysis, and e-Pharmacophore Modeling.
通过抗增殖活性、分子对接、ADME分析和电子药效团建模对新合成的氟化异吲哚酮腙进行研究。
ACS Omega. 2024 Jun 5;9(24):26503-26518. doi: 10.1021/acsomega.4c03014. eCollection 2024 Jun 18.
4
Novel isatin-triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies.基于新型异吲哚酮 - 三唑的硫代氨基脲作为潜在抗癌剂:合成、密度泛函理论及分子对接研究
RSC Adv. 2024 Apr 29;14(20):14051-14067. doi: 10.1039/d4ra01937g. eCollection 2024 Apr 25.
5
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment.糖尿病与感染:流行病学、发病机制及治疗原则综述。
Diabetologia. 2024 Jul;67(7):1168-1180. doi: 10.1007/s00125-024-06102-x. Epub 2024 Feb 20.
6
Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.靛红连接含卤素酰腙衍生物作为具有神经保护作用的单胺氧化酶抑制剂。
Sci Rep. 2024 Jan 13;14(1):1264. doi: 10.1038/s41598-024-51728-x.
7
Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments.糖尿病:分类、介质和并发症;寻找新有效治疗方法的潜在靶点的途径。
Biomed Pharmacother. 2023 Dec;168:115734. doi: 10.1016/j.biopha.2023.115734. Epub 2023 Oct 17.
8
Recent biological applications of heterocyclic hybrids containing -triazine scaffold.含三嗪骨架的杂环杂化物的近期生物学应用。
RSC Adv. 2023 Oct 17;13(43):30462-30490. doi: 10.1039/d3ra05953g. eCollection 2023 Oct 11.
9
Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management.分子对接作为一种工具,用于发现疾病管理中营养保健品的分子靶标。
Sci Rep. 2023 Aug 17;13(1):13398. doi: 10.1038/s41598-023-40160-2.
10
Triazolothiadiazoles and triazolothiadiazines as potent α-glucosidase inhibitors: Mechanistic insights from kinetics studies, molecular docking and dynamics simulations.作为强效α-葡萄糖苷酶抑制剂的三唑并噻二唑和三唑并噻二嗪:来自动力学研究、分子对接和动力学模拟的机理见解
Int J Biol Macromol. 2023 Oct 1;250:126227. doi: 10.1016/j.ijbiomac.2023.126227. Epub 2023 Aug 8.